BACKGROUND: Vancomycin-resistant enterococci (VRE) have spread worldwide. OBJECTIVE: To systematically review VRE outbreaks and estimate the pooled basic reproductive rate (R0) of VRE. METHODS: Eligible studies criteria were (1) published within 10 years, (2) report outbreak details, (3) involve 1 center, (4) estimate epidemic duration, and (5) concern adults. Descriptive analysis included number of index cases, secondary cases, and screened patients; infection control measures; and definition of contact patients. R0 was estimated by the equation R 0=(ln2) D/t d+1, with D as the generation time and t d as the doubling time. RESULTS: Thirteen VRE outbreaks were retained from 180 articles and, among them, 10 were kept for R0 calculation. The mean (range) number of index cases was 2.3 (1-8) and the mean (range) number of secondary cases was 15 (3-56). The mean (range) number of screened patients was 174 (32-509), with pooled VRE prevalence of 5.4% (95% CI, 4.5%-6.3%). Contact precautions were reported in 12 studies (92%), wards were closed in 7 (54%), with cohorting in 6 (46%). Two major screening policies were implemented: (1) a surveillance program in the unit or hospital (7 studies [54%]) and (2) screening of selected contact patients (6 studies [46%]). The pooled R0 of VRE was 1.32 (interquartile range, 1.03-1.46). CONCLUSION: We discerned considerable heterogeneity in screening policies during VRE outbreaks. Pooled R 0 was higher than 1, confirming the epidemic nature of VRE.
BACKGROUND:Vancomycin-resistant enterococci (VRE) have spread worldwide. OBJECTIVE: To systematically review VRE outbreaks and estimate the pooled basic reproductive rate (R0) of VRE. METHODS: Eligible studies criteria were (1) published within 10 years, (2) report outbreak details, (3) involve 1 center, (4) estimate epidemic duration, and (5) concern adults. Descriptive analysis included number of index cases, secondary cases, and screened patients; infection control measures; and definition of contact patients. R0 was estimated by the equation R 0=(ln2) D/t d+1, with D as the generation time and t d as the doubling time. RESULTS: Thirteen VRE outbreaks were retained from 180 articles and, among them, 10 were kept for R0 calculation. The mean (range) number of index cases was 2.3 (1-8) and the mean (range) number of secondary cases was 15 (3-56). The mean (range) number of screened patients was 174 (32-509), with pooled VRE prevalence of 5.4% (95% CI, 4.5%-6.3%). Contact precautions were reported in 12 studies (92%), wards were closed in 7 (54%), with cohorting in 6 (46%). Two major screening policies were implemented: (1) a surveillance program in the unit or hospital (7 studies [54%]) and (2) screening of selected contact patients (6 studies [46%]). The pooled R0 of VRE was 1.32 (interquartile range, 1.03-1.46). CONCLUSION: We discerned considerable heterogeneity in screening policies during VRE outbreaks. Pooled R 0 was higher than 1, confirming the epidemic nature of VRE.
Authors: David M P De Oliveira; Brian M Forde; Timothy J Kidd; Patrick N A Harris; Mark A Schembri; Scott A Beatson; David L Paterson; Mark J Walker Journal: Clin Microbiol Rev Date: 2020-05-13 Impact factor: 26.132
Authors: Vanessa Wiltsie; Skye Travis; Madeline R Shay; Zachary Simmons; Patrick Frantom; Matthew K Thompson Journal: Protein Sci Date: 2021-12-22 Impact factor: 6.725
Authors: Stefanie Kampmeier; Dennis Knaack; Annelene Kossow; Stefanie Willems; Christoph Schliemann; Wolfgang E Berdel; Frank Kipp; Alexander Mellmann Journal: Antimicrob Resist Infect Control Date: 2017-05-16 Impact factor: 4.887
Authors: Nasstasja Wassilew; Helena Mb Seth-Smith; Eveline Rolli; Yvonne Fietze; Carlo Casanova; Urs Führer; Adrian Egli; Jonas Marschall; Niccolò Buetti Journal: Euro Surveill Date: 2018-07
Authors: Franziska Hofmann; Ursel Heudorf; Katrin Steul; Thomas A Wichelhaus; Silke Besier; Michael Hogardt; Daniel Hack; Elvira Steinmann; Volkhard A J Kempf; Claudia Reinheimer Journal: GMS Hyg Infect Control Date: 2020-04-23
Authors: J M van Niekerk; M Lokate; L M A Braakman-Jansen; J E W C van Gemert-Pijnen; A Stein Journal: BMC Infect Dis Date: 2022-01-20 Impact factor: 3.090